nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—Blood amylase increased—Telbivudine—hepatitis B	0.0237	0.0262	CcSEcCtD
Raltegravir—UGT1A1—blood plasma—hepatitis B	0.0179	0.309	CbGeAlD
Raltegravir—Lipase increased—Telbivudine—hepatitis B	0.0176	0.0195	CcSEcCtD
Raltegravir—Hepatitis C—Lamivudine—hepatitis B	0.0168	0.0186	CcSEcCtD
Raltegravir—CCR1—blood—hepatitis B	0.016	0.275	CbGeAlD
Raltegravir—Hepatitis B—Lamivudine—hepatitis B	0.016	0.0177	CcSEcCtD
Raltegravir—Lipodystrophy acquired—Lamivudine—hepatitis B	0.0139	0.0154	CcSEcCtD
Raltegravir—Lipohypertrophy—Lamivudine—hepatitis B	0.0133	0.0148	CcSEcCtD
Raltegravir—Basedow's disease—Lamivudine—hepatitis B	0.0133	0.0148	CcSEcCtD
Raltegravir—Flank pain—Telbivudine—hepatitis B	0.0128	0.0142	CcSEcCtD
Raltegravir—CCR1—liver—hepatitis B	0.0125	0.215	CbGeAlD
Raltegravir—Amylase increased—Telbivudine—hepatitis B	0.0109	0.012	CcSEcCtD
Raltegravir—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.0108	0.012	CcSEcCtD
Raltegravir—Nephropathy toxic—Adefovir Dipivoxil—hepatitis B	0.0107	0.0118	CcSEcCtD
Raltegravir—Platelet count decreased—Entecavir—hepatitis B	0.0106	0.0117	CcSEcCtD
Raltegravir—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.00983	0.0109	CcSEcCtD
Raltegravir—Hepatic steatosis—Lamivudine—hepatitis B	0.00965	0.0107	CcSEcCtD
Raltegravir—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00901	0.00997	CcSEcCtD
Raltegravir—Myopathy—Adefovir Dipivoxil—hepatitis B	0.00876	0.00969	CcSEcCtD
Raltegravir—Autoimmune disorder—Lamivudine—hepatitis B	0.00873	0.00966	CcSEcCtD
Raltegravir—Glycosuria—Entecavir—hepatitis B	0.00777	0.0086	CcSEcCtD
Raltegravir—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.00758	0.00839	CcSEcCtD
Raltegravir—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00751	0.00831	CcSEcCtD
Raltegravir—Myopathy—Telbivudine—hepatitis B	0.00737	0.00816	CcSEcCtD
Raltegravir—Opportunistic infection—Lamivudine—hepatitis B	0.00723	0.008	CcSEcCtD
Raltegravir—UGT1A1—blood—hepatitis B	0.00656	0.113	CbGeAlD
Raltegravir—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.00614	0.0068	CcSEcCtD
Raltegravir—Amylase increased—Lamivudine—hepatitis B	0.00612	0.00677	CcSEcCtD
Raltegravir—Rhabdomyolysis—Telbivudine—hepatitis B	0.00584	0.00647	CcSEcCtD
Raltegravir—Chest discomfort—Telbivudine—hepatitis B	0.00584	0.00647	CcSEcCtD
Raltegravir—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00554	0.00613	CcSEcCtD
Raltegravir—Neck pain—Telbivudine—hepatitis B	0.00523	0.00579	CcSEcCtD
Raltegravir—Musculoskeletal pain—Telbivudine—hepatitis B	0.00523	0.00579	CcSEcCtD
Raltegravir—Suicide attempt—Lamivudine—hepatitis B	0.00514	0.00568	CcSEcCtD
Raltegravir—UGT1A1—liver—hepatitis B	0.00513	0.0884	CbGeAlD
Raltegravir—Hepatic failure—Entecavir—hepatitis B	0.00508	0.00563	CcSEcCtD
Raltegravir—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00496	0.00549	CcSEcCtD
Raltegravir—Completed suicide—Lamivudine—hepatitis B	0.00496	0.00548	CcSEcCtD
Raltegravir—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00468	0.00518	CcSEcCtD
Raltegravir—Folliculitis—Lamivudine—hepatitis B	0.00464	0.00513	CcSEcCtD
Raltegravir—Blood triglycerides increased—Lamivudine—hepatitis B	0.00445	0.00492	CcSEcCtD
Raltegravir—Blood creatinine increased—Entecavir—hepatitis B	0.00428	0.00474	CcSEcCtD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CXCL10—hepatitis B	0.00427	0.112	CbGpPWpGaD
Raltegravir—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00423	0.00468	CcSEcCtD
Raltegravir—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00418	0.00462	CcSEcCtD
Raltegravir—Abdominal pain upper—Entecavir—hepatitis B	0.00417	0.00462	CcSEcCtD
Raltegravir—Myopathy—Lamivudine—hepatitis B	0.00416	0.0046	CcSEcCtD
Raltegravir—Renal impairment—Telbivudine—hepatitis B	0.00394	0.00436	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00393	0.00435	CcSEcCtD
Raltegravir—Pain in extremity—Telbivudine—hepatitis B	0.00375	0.00415	CcSEcCtD
Raltegravir—Migraine—Telbivudine—hepatitis B	0.00369	0.00409	CcSEcCtD
Raltegravir—Neutropenia—Entecavir—hepatitis B	0.00369	0.00409	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Entecavir—hepatitis B	0.00367	0.00406	CcSEcCtD
Raltegravir—Hyperglycaemia—Entecavir—hepatitis B	0.00356	0.00394	CcSEcCtD
Raltegravir—Dysphonia—Lamivudine—hepatitis B	0.00354	0.00392	CcSEcCtD
Raltegravir—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00349	0.00386	CcSEcCtD
Raltegravir—Renal failure—Entecavir—hepatitis B	0.00346	0.00383	CcSEcCtD
Raltegravir—Abdominal pain upper—Telbivudine—hepatitis B	0.00343	0.00379	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00338	0.00374	CcSEcCtD
Raltegravir—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00338	0.00374	CcSEcCtD
Raltegravir—Haematuria—Entecavir—hepatitis B	0.00336	0.00371	CcSEcCtD
Raltegravir—Nasopharyngitis—Telbivudine—hepatitis B	0.00336	0.00371	CcSEcCtD
Raltegravir—Hepatobiliary disease—Entecavir—hepatitis B	0.00333	0.00368	CcSEcCtD
Raltegravir—Gastritis—Telbivudine—hepatitis B	0.00332	0.00368	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00331	0.00366	CcSEcCtD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CCR5—hepatitis B	0.00331	0.0868	CbGpPWpGaD
Raltegravir—Rhabdomyolysis—Lamivudine—hepatitis B	0.00329	0.00364	CcSEcCtD
Raltegravir—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00328	0.00362	CcSEcCtD
Raltegravir—Abdominal distension—Telbivudine—hepatitis B	0.00327	0.00361	CcSEcCtD
Raltegravir—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00325	0.00359	CcSEcCtD
Raltegravir—Influenza—Telbivudine—hepatitis B	0.00324	0.00359	CcSEcCtD
Raltegravir—Hepatitis—Entecavir—hepatitis B	0.00316	0.0035	CcSEcCtD
Raltegravir—Oedema peripheral—Entecavir—hepatitis B	0.00311	0.00345	CcSEcCtD
Raltegravir—Abdominal discomfort—Telbivudine—hepatitis B	0.00311	0.00344	CcSEcCtD
Raltegravir—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00308	0.00341	CcSEcCtD
Raltegravir—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00308	0.00341	CcSEcCtD
Raltegravir—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00305	0.00337	CcSEcCtD
Raltegravir—Neutropenia—Telbivudine—hepatitis B	0.00303	0.00336	CcSEcCtD
Raltegravir—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00303	0.00335	CcSEcCtD
Raltegravir—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00302	0.00334	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00301	0.00334	CcSEcCtD
Raltegravir—Inflammation—Lamivudine—hepatitis B	0.003	0.00332	CcSEcCtD
Raltegravir—Musculoskeletal pain—Lamivudine—hepatitis B	0.00295	0.00326	CcSEcCtD
Raltegravir—Eructation—Lamivudine—hepatitis B	0.00286	0.00317	CcSEcCtD
Raltegravir—Immune system disorder—Entecavir—hepatitis B	0.00286	0.00316	CcSEcCtD
Raltegravir—Renal failure—Telbivudine—hepatitis B	0.00284	0.00315	CcSEcCtD
Raltegravir—Neuropathy peripheral—Telbivudine—hepatitis B	0.00284	0.00314	CcSEcCtD
Raltegravir—Alopecia—Entecavir—hepatitis B	0.00279	0.00309	CcSEcCtD
Raltegravir—Mental disorder—Entecavir—hepatitis B	0.00277	0.00306	CcSEcCtD
Raltegravir—Malnutrition—Entecavir—hepatitis B	0.00275	0.00304	CcSEcCtD
Raltegravir—Hepatobiliary disease—Telbivudine—hepatitis B	0.00274	0.00303	CcSEcCtD
Raltegravir—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00268	0.00297	CcSEcCtD
Raltegravir—CCR1—Peptide GPCRs—CCR5—hepatitis B	0.00265	0.0695	CbGpPWpGaD
Raltegravir—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00265	0.00293	CcSEcCtD
Raltegravir—Gynaecomastia—Lamivudine—hepatitis B	0.00261	0.00288	CcSEcCtD
Raltegravir—Back pain—Adefovir Dipivoxil—hepatitis B	0.0026	0.00287	CcSEcCtD
Raltegravir—Hepatitis—Telbivudine—hepatitis B	0.0026	0.00287	CcSEcCtD
Raltegravir—Hypoaesthesia—Telbivudine—hepatitis B	0.00258	0.00286	CcSEcCtD
Raltegravir—Connective tissue disorder—Telbivudine—hepatitis B	0.00255	0.00282	CcSEcCtD
Raltegravir—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00248	0.00275	CcSEcCtD
Raltegravir—Lymphadenopathy—Lamivudine—hepatitis B	0.00248	0.00274	CcSEcCtD
Raltegravir—Sleep disorder—Lamivudine—hepatitis B	0.00244	0.0027	CcSEcCtD
Raltegravir—Gastroenteritis—Lamivudine—hepatitis B	0.00239	0.00264	CcSEcCtD
Raltegravir—Cough—Adefovir Dipivoxil—hepatitis B	0.00234	0.00259	CcSEcCtD
Raltegravir—Mediastinal disorder—Telbivudine—hepatitis B	0.00234	0.00259	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00233	0.00257	CcSEcCtD
Raltegravir—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00229	0.00253	CcSEcCtD
Raltegravir—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00229	0.00253	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00227	0.00251	CcSEcCtD
Raltegravir—Malnutrition—Telbivudine—hepatitis B	0.00226	0.0025	CcSEcCtD
Raltegravir—Infection—Entecavir—hepatitis B	0.00223	0.00247	CcSEcCtD
Raltegravir—Renal impairment—Lamivudine—hepatitis B	0.00222	0.00246	CcSEcCtD
Raltegravir—Dysgeusia—Telbivudine—hepatitis B	0.00221	0.00245	CcSEcCtD
Raltegravir—Nervous system disorder—Entecavir—hepatitis B	0.0022	0.00244	CcSEcCtD
Raltegravir—Back pain—Telbivudine—hepatitis B	0.00219	0.00242	CcSEcCtD
Raltegravir—Skin disorder—Entecavir—hepatitis B	0.00218	0.00241	CcSEcCtD
Raltegravir—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00215	0.00238	CcSEcCtD
Raltegravir—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00215	0.00237	CcSEcCtD
Raltegravir—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00213	0.00235	CcSEcCtD
Raltegravir—Ill-defined disorder—Telbivudine—hepatitis B	0.0021	0.00232	CcSEcCtD
Raltegravir—Migraine—Lamivudine—hepatitis B	0.00208	0.0023	CcSEcCtD
Raltegravir—Affect lability—Lamivudine—hepatitis B	0.00208	0.0023	CcSEcCtD
Raltegravir—Malaise—Telbivudine—hepatitis B	0.00204	0.00226	CcSEcCtD
Raltegravir—Insomnia—Entecavir—hepatitis B	0.00203	0.00225	CcSEcCtD
Raltegravir—Mood swings—Lamivudine—hepatitis B	0.002	0.00222	CcSEcCtD
Raltegravir—Somnolence—Entecavir—hepatitis B	0.002	0.00221	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.002	0.00221	CcSEcCtD
Raltegravir—Dyspepsia—Entecavir—hepatitis B	0.00198	0.00219	CcSEcCtD
Raltegravir—Cough—Telbivudine—hepatitis B	0.00197	0.00218	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Entecavir—hepatitis B	0.00194	0.00215	CcSEcCtD
Raltegravir—Fatigue—Entecavir—hepatitis B	0.00194	0.00214	CcSEcCtD
Raltegravir—Abdominal pain upper—Lamivudine—hepatitis B	0.00193	0.00214	CcSEcCtD
Raltegravir—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00193	0.00213	CcSEcCtD
Raltegravir—Myalgia—Telbivudine—hepatitis B	0.00192	0.00213	CcSEcCtD
Raltegravir—Arthralgia—Telbivudine—hepatitis B	0.00192	0.00213	CcSEcCtD
Raltegravir—Chest pain—Telbivudine—hepatitis B	0.00192	0.00213	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00191	0.00211	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.0019	0.00211	CcSEcCtD
Raltegravir—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0019	0.00211	CcSEcCtD
Raltegravir—Discomfort—Telbivudine—hepatitis B	0.0019	0.0021	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00189	0.00209	CcSEcCtD
Raltegravir—Nasopharyngitis—Lamivudine—hepatitis B	0.00189	0.00209	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00187	0.00206	CcSEcCtD
Raltegravir—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00185	0.0486	CbGpPWpGaD
Raltegravir—Abdominal distension—Lamivudine—hepatitis B	0.00184	0.00204	CcSEcCtD
Raltegravir—Gastrointestinal pain—Entecavir—hepatitis B	0.00184	0.00203	CcSEcCtD
Raltegravir—Influenza—Lamivudine—hepatitis B	0.00183	0.00202	CcSEcCtD
Raltegravir—Nervous system disorder—Telbivudine—hepatitis B	0.00181	0.002	CcSEcCtD
Raltegravir—Thrombocytopenia—Telbivudine—hepatitis B	0.00181	0.002	CcSEcCtD
Raltegravir—Skin disorder—Telbivudine—hepatitis B	0.00179	0.00198	CcSEcCtD
Raltegravir—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00179	0.00198	CcSEcCtD
Raltegravir—Abdominal pain—Entecavir—hepatitis B	0.00178	0.00196	CcSEcCtD
Raltegravir—Body temperature increased—Entecavir—hepatitis B	0.00178	0.00196	CcSEcCtD
Raltegravir—Bronchitis—Lamivudine—hepatitis B	0.00176	0.00195	CcSEcCtD
Raltegravir—Abdominal discomfort—Lamivudine—hepatitis B	0.00175	0.00194	CcSEcCtD
Raltegravir—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00173	0.00192	CcSEcCtD
Raltegravir—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00173	0.00192	CcSEcCtD
Raltegravir—Neutropenia—Lamivudine—hepatitis B	0.00171	0.00189	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00168	0.00186	CcSEcCtD
Raltegravir—Insomnia—Telbivudine—hepatitis B	0.00167	0.00185	CcSEcCtD
Raltegravir—Paraesthesia—Telbivudine—hepatitis B	0.00166	0.00183	CcSEcCtD
Raltegravir—Hyperglycaemia—Lamivudine—hepatitis B	0.00165	0.00182	CcSEcCtD
Raltegravir—Depression—Lamivudine—hepatitis B	0.00163	0.0018	CcSEcCtD
Raltegravir—Dyspepsia—Telbivudine—hepatitis B	0.00162	0.0018	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00162	0.00179	CcSEcCtD
Raltegravir—Asthenia—Entecavir—hepatitis B	0.00161	0.00178	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00161	0.0421	CbGpPWpGaD
Raltegravir—Renal failure—Lamivudine—hepatitis B	0.0016	0.00177	CcSEcCtD
Raltegravir—Neuropathy peripheral—Lamivudine—hepatitis B	0.0016	0.00177	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00159	0.00176	CcSEcCtD
Raltegravir—Fatigue—Telbivudine—hepatitis B	0.00159	0.00176	CcSEcCtD
Raltegravir—Pain—Telbivudine—hepatitis B	0.00158	0.00175	CcSEcCtD
Raltegravir—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00157	0.00174	CcSEcCtD
Raltegravir—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00155	0.00172	CcSEcCtD
Raltegravir—Hepatobiliary disease—Lamivudine—hepatitis B	0.00154	0.00171	CcSEcCtD
Raltegravir—Epistaxis—Lamivudine—hepatitis B	0.00154	0.0017	CcSEcCtD
Raltegravir—Diarrhoea—Entecavir—hepatitis B	0.00154	0.0017	CcSEcCtD
Raltegravir—Feeling abnormal—Telbivudine—hepatitis B	0.00152	0.00168	CcSEcCtD
Raltegravir—Gastrointestinal pain—Telbivudine—hepatitis B	0.00151	0.00167	CcSEcCtD
Raltegravir—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.0015	0.00166	CcSEcCtD
Raltegravir—Dizziness—Entecavir—hepatitis B	0.00148	0.00164	CcSEcCtD
Raltegravir—Hepatitis—Lamivudine—hepatitis B	0.00146	0.00162	CcSEcCtD
Raltegravir—Abdominal pain—Telbivudine—hepatitis B	0.00146	0.00161	CcSEcCtD
Raltegravir—Body temperature increased—Telbivudine—hepatitis B	0.00146	0.00161	CcSEcCtD
Raltegravir—Hypoaesthesia—Lamivudine—hepatitis B	0.00146	0.00161	CcSEcCtD
Raltegravir—Connective tissue disorder—Lamivudine—hepatitis B	0.00144	0.00159	CcSEcCtD
Raltegravir—Vomiting—Entecavir—hepatitis B	0.00143	0.00158	CcSEcCtD
Raltegravir—Rash—Entecavir—hepatitis B	0.00142	0.00157	CcSEcCtD
Raltegravir—Dermatitis—Entecavir—hepatitis B	0.00141	0.00157	CcSEcCtD
Raltegravir—Headache—Entecavir—hepatitis B	0.00141	0.00156	CcSEcCtD
Raltegravir—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00139	0.00154	CcSEcCtD
Raltegravir—Erythema multiforme—Lamivudine—hepatitis B	0.00138	0.00153	CcSEcCtD
Raltegravir—Rash—Adefovir Dipivoxil—hepatitis B	0.00138	0.00153	CcSEcCtD
Raltegravir—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00138	0.00153	CcSEcCtD
Raltegravir—Headache—Adefovir Dipivoxil—hepatitis B	0.00137	0.00152	CcSEcCtD
Raltegravir—UGT1A1—Phase II conjugation—GGT2—hepatitis B	0.00136	0.0357	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CXCL10—hepatitis B	0.00135	0.0355	CbGpPWpGaD
Raltegravir—Nausea—Entecavir—hepatitis B	0.00133	0.00148	CcSEcCtD
Raltegravir—Asthenia—Telbivudine—hepatitis B	0.00132	0.00146	CcSEcCtD
Raltegravir—Immune system disorder—Lamivudine—hepatitis B	0.00132	0.00146	CcSEcCtD
Raltegravir—Mediastinal disorder—Lamivudine—hepatitis B	0.00132	0.00146	CcSEcCtD
Raltegravir—Chills—Lamivudine—hepatitis B	0.00131	0.00145	CcSEcCtD
Raltegravir—Pruritus—Telbivudine—hepatitis B	0.00131	0.00144	CcSEcCtD
Raltegravir—Nausea—Adefovir Dipivoxil—hepatitis B	0.0013	0.00144	CcSEcCtD
Raltegravir—Alopecia—Lamivudine—hepatitis B	0.00129	0.00143	CcSEcCtD
Raltegravir—Malnutrition—Lamivudine—hepatitis B	0.00127	0.00141	CcSEcCtD
Raltegravir—Erythema—Lamivudine—hepatitis B	0.00127	0.00141	CcSEcCtD
Raltegravir—Diarrhoea—Telbivudine—hepatitis B	0.00126	0.0014	CcSEcCtD
Raltegravir—Flatulence—Lamivudine—hepatitis B	0.00126	0.00139	CcSEcCtD
Raltegravir—Dysgeusia—Lamivudine—hepatitis B	0.00125	0.00138	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.00125	0.0327	CbGpPWpGaD
Raltegravir—Nervousness—Lamivudine—hepatitis B	0.00124	0.00137	CcSEcCtD
Raltegravir—Back pain—Lamivudine—hepatitis B	0.00123	0.00136	CcSEcCtD
Raltegravir—Dizziness—Telbivudine—hepatitis B	0.00122	0.00135	CcSEcCtD
Raltegravir—Tremor—Lamivudine—hepatitis B	0.00119	0.00132	CcSEcCtD
Raltegravir—Ill-defined disorder—Lamivudine—hepatitis B	0.00118	0.00131	CcSEcCtD
Raltegravir—Anaemia—Lamivudine—hepatitis B	0.00118	0.0013	CcSEcCtD
Raltegravir—Vomiting—Telbivudine—hepatitis B	0.00117	0.0013	CcSEcCtD
Raltegravir—Rash—Telbivudine—hepatitis B	0.00116	0.00129	CcSEcCtD
Raltegravir—Dermatitis—Telbivudine—hepatitis B	0.00116	0.00129	CcSEcCtD
Raltegravir—Headache—Telbivudine—hepatitis B	0.00116	0.00128	CcSEcCtD
Raltegravir—Malaise—Lamivudine—hepatitis B	0.00115	0.00127	CcSEcCtD
Raltegravir—Vertigo—Lamivudine—hepatitis B	0.00114	0.00127	CcSEcCtD
Raltegravir—Cough—Lamivudine—hepatitis B	0.00111	0.00123	CcSEcCtD
Raltegravir—Nausea—Telbivudine—hepatitis B	0.0011	0.00121	CcSEcCtD
Raltegravir—Myalgia—Lamivudine—hepatitis B	0.00108	0.0012	CcSEcCtD
Raltegravir—Chest pain—Lamivudine—hepatitis B	0.00108	0.0012	CcSEcCtD
Raltegravir—Arthralgia—Lamivudine—hepatitis B	0.00108	0.0012	CcSEcCtD
Raltegravir—Anxiety—Lamivudine—hepatitis B	0.00108	0.0012	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.00108	0.0283	CbGpPWpGaD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00108	0.00119	CcSEcCtD
Raltegravir—Discomfort—Lamivudine—hepatitis B	0.00107	0.00119	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—F2—hepatitis B	0.00107	0.028	CbGpPWpGaD
Raltegravir—Dry mouth—Lamivudine—hepatitis B	0.00106	0.00117	CcSEcCtD
Raltegravir—CCR1—G alpha (i) signalling events—CCR5—hepatitis B	0.00105	0.0276	CbGpPWpGaD
Raltegravir—Confusional state—Lamivudine—hepatitis B	0.00105	0.00116	CcSEcCtD
Raltegravir—Infection—Lamivudine—hepatitis B	0.00103	0.00114	CcSEcCtD
Raltegravir—Nervous system disorder—Lamivudine—hepatitis B	0.00102	0.00113	CcSEcCtD
Raltegravir—Thrombocytopenia—Lamivudine—hepatitis B	0.00102	0.00113	CcSEcCtD
Raltegravir—Skin disorder—Lamivudine—hepatitis B	0.00101	0.00112	CcSEcCtD
Raltegravir—Hyperhidrosis—Lamivudine—hepatitis B	0.00101	0.00111	CcSEcCtD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000975	0.0256	CbGpPWpGaD
Raltegravir—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000947	0.00105	CcSEcCtD
Raltegravir—Insomnia—Lamivudine—hepatitis B	0.00094	0.00104	CcSEcCtD
Raltegravir—Paraesthesia—Lamivudine—hepatitis B	0.000934	0.00103	CcSEcCtD
Raltegravir—Somnolence—Lamivudine—hepatitis B	0.000924	0.00102	CcSEcCtD
Raltegravir—Dyspepsia—Lamivudine—hepatitis B	0.000915	0.00101	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—GGT2—hepatitis B	0.000908	0.0238	CbGpPWpGaD
Raltegravir—Decreased appetite—Lamivudine—hepatitis B	0.000904	0.001	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000898	0.000993	CcSEcCtD
Raltegravir—Fatigue—Lamivudine—hepatitis B	0.000896	0.000992	CcSEcCtD
Raltegravir—Pain—Lamivudine—hepatitis B	0.000889	0.000984	CcSEcCtD
Raltegravir—Constipation—Lamivudine—hepatitis B	0.000889	0.000984	CcSEcCtD
Raltegravir—Feeling abnormal—Lamivudine—hepatitis B	0.000857	0.000948	CcSEcCtD
Raltegravir—Gastrointestinal pain—Lamivudine—hepatitis B	0.00085	0.000941	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000835	0.0219	CbGpPWpGaD
Raltegravir—Urticaria—Lamivudine—hepatitis B	0.000826	0.000914	CcSEcCtD
Raltegravir—Body temperature increased—Lamivudine—hepatitis B	0.000822	0.000909	CcSEcCtD
Raltegravir—Abdominal pain—Lamivudine—hepatitis B	0.000822	0.000909	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—CXCL10—hepatitis B	0.00082	0.0215	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000819	0.0215	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GGT2—hepatitis B	0.000796	0.0209	CbGpPWpGaD
Raltegravir—Hypersensitivity—Lamivudine—hepatitis B	0.000766	0.000847	CcSEcCtD
Raltegravir—Asthenia—Lamivudine—hepatitis B	0.000746	0.000825	CcSEcCtD
Raltegravir—Pruritus—Lamivudine—hepatitis B	0.000736	0.000814	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000717	0.0188	CbGpPWpGaD
Raltegravir—Diarrhoea—Lamivudine—hepatitis B	0.000711	0.000787	CcSEcCtD
Raltegravir—Dizziness—Lamivudine—hepatitis B	0.000687	0.000761	CcSEcCtD
Raltegravir—Vomiting—Lamivudine—hepatitis B	0.000661	0.000731	CcSEcCtD
Raltegravir—Rash—Lamivudine—hepatitis B	0.000656	0.000725	CcSEcCtD
Raltegravir—Dermatitis—Lamivudine—hepatitis B	0.000655	0.000725	CcSEcCtD
Raltegravir—Headache—Lamivudine—hepatitis B	0.000651	0.000721	CcSEcCtD
Raltegravir—UGT1A1—Phase II conjugation—GGT1—hepatitis B	0.000644	0.0169	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCR5—hepatitis B	0.000636	0.0167	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—RIT2—hepatitis B	0.00063	0.0165	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SAG—hepatitis B	0.00063	0.0165	CbGpPWpGaD
Raltegravir—Nausea—Lamivudine—hepatitis B	0.000618	0.000683	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—CYP2A6—hepatitis B	0.00055	0.0144	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—F2—hepatitis B	0.000546	0.0143	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000525	0.0138	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP2A6—hepatitis B	0.000482	0.0127	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000467	0.0122	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCL10—hepatitis B	0.000464	0.0122	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—GGT1—hepatitis B	0.000429	0.0113	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCL10—hepatitis B	0.000421	0.011	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GGT1—hepatitis B	0.000377	0.00988	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000364	0.00955	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR5—hepatitis B	0.00036	0.00943	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.00034	0.00891	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR5—hepatitis B	0.000327	0.00856	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—F2—hepatitis B	0.000308	0.00809	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—F2—hepatitis B	0.00028	0.00735	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL10—hepatitis B	0.000249	0.00652	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IL2—hepatitis B	0.000208	0.00545	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR5—hepatitis B	0.000193	0.00506	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL2—hepatitis B	0.000189	0.00495	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—F2—hepatitis B	0.000165	0.00434	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TGFB1—hepatitis B	0.000144	0.00379	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AKR1B1—hepatitis B	0.000142	0.00373	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GGT2—hepatitis B	0.000136	0.00357	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL2—hepatitis B	0.000111	0.00292	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6—hepatitis B	0.000111	0.00291	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CTNNB1—hepatitis B	0.000108	0.00282	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CDKN1A—hepatitis B	0.000105	0.00276	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTEN—hepatitis B	0.000105	0.00275	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NFKB1—hepatitis B	0.000104	0.00274	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TGFB1—hepatitis B	8.69e-05	0.00228	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP2A6—hepatitis B	8.25e-05	0.00216	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT2—hepatitis B	7.46e-05	0.00196	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TP53—hepatitis B	7.16e-05	0.00188	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6—hepatitis B	6.55e-05	0.00172	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT1—hepatitis B	6.44e-05	0.00169	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GGT1—hepatitis B	6.44e-05	0.00169	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—hepatitis B	3.43e-05	0.000899	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTEN—hepatitis B	2.61e-05	0.000686	CbGpPWpGaD
